Logani Sanjay, Lu Danielle, Quint Wim G V, Ellenson Lora H, Pirog Edyta C
Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Mod Pathol. 2003 Aug;16(8):735-41. doi: 10.1097/01.MP.0000081051.55284.2A.
Histologic criteria of low-grade vulvar/vaginal intraepithelial neoplasia (VIN1/VAIN1) are well established; however, a significant interobserver variability in diagnosing VIN1/VAIN1 has been reported. The goal of this study was to evaluate the utility of MIB-1 immunostaining as an adjunct test to increase the diagnostic accuracy in equivocal cases of VIN1/VAIN1. The second goal was to examine the distribution of low- and high-oncogenic risk human papillomaviruses (HPVs) in VIN1/VAIN1 lesions. Consecutive vulvar/vaginal biopsies originally diagnosed as VIN1/VAIN1 (n = 43) or benign (n = 20) were reviewed by two pathologists to obtain a consensus diagnosis. The diagnosis was further confirmed with HPV testing using Short PCR Fragment 10 and Line Probe Assay. MIB-1 immunostaining was performed, and positive staining was defined as a cluster of two or more stained nuclei in the upper two thirds of the epithelial thickness. After verification of the diagnosis using the consensus histologic review and HPV detection as an objective confirmatory test, 31% of cases originally diagnosed as VIN1/VAIN1 were identified as being overdiagnosed. The sensitivity and the specificity of MIB-1 staining for identifying VIN1/VAIN1 were 0.96 and 0.90, respectively. Seventy percent of VIN1 cases were associated with low-risk viral types. In contrast, the majority (84%) of VAIN1 cases were associated with high-risk HPVs. In conclusion, MIB-1 staining is sensitive and specific for identifying VIN1/VAIN1, helpful in verifying the diagnosis in equivocal cases.
低级别外阴/阴道上皮内瘤变(VIN1/VAIN1)的组织学标准已明确确立;然而,据报道在诊断VIN1/VAIN1时观察者间存在显著差异。本研究的目的是评估MIB-1免疫染色作为辅助检查在VIN1/VAIN1疑难病例中提高诊断准确性的效用。第二个目的是检查低致癌风险和高致癌风险人乳头瘤病毒(HPV)在VIN1/VAIN1病变中的分布情况。两位病理学家对最初诊断为VIN1/VAIN1(n = 43)或良性(n = 20)的连续外阴/阴道活检标本进行复查以获得共识诊断。使用短PCR片段10和线性探针分析进行HPV检测进一步确诊。进行MIB-1免疫染色,阳性染色定义为在上皮厚度上三分之二处有两个或更多染色细胞核的聚集。在使用共识组织学复查和HPV检测作为客观确证性检查对诊断进行验证后,最初诊断为VIN1/VAIN1的病例中有31%被确定为过度诊断。MIB-1染色识别VIN1/VAIN1的敏感性和特异性分别为0.96和0.90。70%的VIN1病例与低风险病毒类型相关。相比之下,大多数(84%)VAIN1病例与高风险HPV相关。总之,MIB-1染色对识别VIN1/VAIN1敏感且特异,有助于在疑难病例中验证诊断。